Epstein-Barr virus-transformed lymphoblastoid cell lines as antigen-presenting cells and “Augmenting” cells for human CMV-specific Th clones
✍ Scribed by Yung-Nan Liu; Susan Fuad; Richard C. Gehrz
- Book ID
- 113133904
- Publisher
- Elsevier Science
- Year
- 1987
- Tongue
- English
- Weight
- 795 KB
- Volume
- 108
- Category
- Article
- ISSN
- 0008-8749
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Analysis of antigen uptake and presentation by Epstein-Barr virus-transformed human lymphoblastoid B cells* Epstein-Barr virus-transformed human B cells (EBV-B cells), but not resting B cells or B cells activated by T cell-derived factors, have been shown to support the proliferation of tetanus
## Abstract EBV‐specific cytotoxic T cells (Tc)^1^ induced __in vitro__ have continuously proliferated __in vitro__ for over 9 months. The long‐term maintenance of the Tc growth was dependent on periodic supplementation of both irrediated EBV‐transformed autologous lymphoblastoid cell line (LCL) ce
## Abstract The human lymphoblastoid cell line 6410 was superinfected with P3HR‐1 derived Epstein‐Barr virus. Subsequent to the first cycle of infection, characterized by early (EA) and virus capsid (VCA) antigen synthesis, the culture, designated 6410‐EBV, continued to synthesize VCA. Further immu